• 659 Citations
  • 10 h-Index
1977 …2024
If you made any changes in Pure, your changes will be visible here soon.

Personal profile

Area of Expertise

For more than 38 years, I have been involved in the field of gerontology and health services management. My research has been sponsored by grants from the Center for Medicare and Medicaid Innovation, National Institutes of Health, the National Science Foundation, the Administration on Aging, and various foundations. I am the Principal Investigator for the Texas Alzheimer’s Research Consortium (TARC) at UNTHSC. TARC is a state-funded collaboration between five of the state’s leading medical research institutions to improve early diagnosis, treatment, and prevention of Alzheimer’s disease.

Education/Academic qualification

PhD in Sociology, Wayne State University

MS in Sociology, Wayne State University

BS in Management, Wayne State University

Fingerprint Dive into the research topics where Thomas Fairchild is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 9 Similar Profiles
Alzheimer Disease Medicine & Life Sciences
Nursing Staff Medicine & Life Sciences
Biomarkers Medicine & Life Sciences
Nursing Homes Medicine & Life Sciences
Single Nucleotide Polymorphism Medicine & Life Sciences
Housing for the Elderly Medicine & Life Sciences
Genome Medicine & Life Sciences
1-Alkyl-2-acetylglycerophosphocholine Esterase Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2012 2024

Research Output 1977 2019

  • 659 Citations
  • 10 h-Index
  • 21 Article

Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing

Alzheimer Disease Genetics Consortium (ADGC), The European Alzheimer’s Disease Initiative (EADI), Cohorts for Heart and Aging Research in Genomic Epidemiology Consortium (CHARGE), & Genetic and Environmental Risk in AD/Defining Genetic, Polygenic and Environmental Risk for Alzheimer’s Disease Consortium (GERAD/PERADES), 1 Mar 2019, In : Nature Genetics. 51, 3, p. 414-430 17 p.

Research output: Contribution to journalArticle

Alzheimer Disease
Serum Amyloid A Protein

Genetically elevated high-density lipoprotein cholesterol through the cholesteryl ester transfer protein gene does not associate with risk of Alzheimer's disease

International Genomics of Alzheimer's Project (IGAP), ARUK Consortium & GERAD/PERADES, CHARGE, ADGC, EADI, 1 Jan 2018, In : Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring. 10, p. 595-598 4 p.

Research output: Contribution to journalArticle

Cholesterol Ester Transfer Proteins
HDL Cholesterol
Alzheimer Disease
Single Nucleotide Polymorphism
1 Citation (Scopus)

Odorant Item Specific Olfactory Identification Deficit May Differentiate Alzheimer Disease From Aging

Texas Alzheimer's Research, Care Consortium, Aug 2018, In : American Journal of Geriatric Psychiatry. 26, 8, p. 835-846 12 p.

Research output: Contribution to journalArticle

Alzheimer Disease
Healthy Volunteers
8 Citations (Scopus)

Sex-specific association of apolipoprotein e with cerebrospinal fluid levels of tau

Alzheimer's Disease Genetics Consortium and the Alzheimer's Disease Neuroimaging Initiative, 1 Aug 2018, In : JAMA Neurology. 75, 8, p. 989-998 10 p.

Research output: Contribution to journalArticle

Apolipoproteins E
Cerebrospinal Fluid
Alzheimer Disease
Neurofibrillary Tangles
4 Citations (Scopus)

Sex-specific genetic predictors of Alzheimer’s disease biomarkers

Alzheimer’S Disease Neuroimaging Initiative (Adni) & The Alzheimer Disease Genetics Consortium (Adgc), 1 Dec 2018, In : Acta Neuropathologica. 136, 6, p. 857-872 16 p.

Research output: Contribution to journalArticle

Alzheimer Disease
Genome-Wide Association Study